Skip to main content
Clinical Trials/NCT05712564
NCT05712564
Completed
Not Applicable

Observational Survey on Fatigue Levels in Relation to Depressive Disorders and Insomnia in Adult Patients with Marfan Syndrome and Hypermobile Ehlers-Danlos Syndrome

IRCCS Policlinico S. Donato1 site in 1 country282 target enrollmentJanuary 9, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Rare Diseases
Sponsor
IRCCS Policlinico S. Donato
Enrollment
282
Locations
1
Primary Endpoint
Physical and psychological features
Status
Completed
Last Updated
last year

Overview

Brief Summary

The goal of this observational study is to describe and assess the presence of perceived fatigue in subjects with MFS and EDS. the main question it aims to answer through the FSS instrument is:

  • The relationship of fatigue with physical and psychological characteristics, the presence of depressive disorders and insomnia.

Detailed Description

Marfan syndrome (MFS) and hypermobile Ehlers-Danlos Syndrome (hEDS) are rare diseases of the connective tissue presenting peculiar symptoms as well as high mortality due to complications related to dilatation and dissection of the ascending aorta and great arteries. Life expectancy of patients with MFS and hEDS has improved markedly in the last decades, but still remains lower than that of the general population. Fatigue represent one of the main causes that limit the quality of life in these populations. The Fatigue Severity Scale (FSS) is a questionnaire widely used in populations with chronic diseases and has been previously applied in MFS and hEDS population: indeed, fatigue interferes with activities of daily living and the presence of chronic pain. However, the potential correlations that fatigue may have with different aspects of psychological well-being (i.e. insomnia and depression) were not investigated in MFS and hEDS.

Registry
clinicaltrials.gov
Start Date
January 9, 2023
End Date
May 9, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
IRCCS Policlinico S. Donato
Responsible Party
Principal Investigator
Principal Investigator

Alessandro Pini

Principal Investigator

IRCCS Policlinico S. Donato

Eligibility Criteria

Inclusion Criteria

  • Subjects aged 18 or greater with clinical and/or genetic diagnosis of Marfan syndrome;
  • Subjects aged 18 or greater with clinical and/or genetic diagnosis of hypermobile Ehlers-Danlos syndrome;
  • Signed informed consent;
  • Ability to speak, read and write in Italian.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Physical and psychological features

Time Frame: 10 months

The mean, median, standard deviation and interquartile range will be used for continuous variables, whereas frequency and percentage will be applied for nominal and categorical variables. The Shapiro-Wilks test will be used to assess the Gaussian distributions.

Secondary Outcomes

  • Psychosocial variables(10 months)

Study Sites (1)

Loading locations...

Similar Trials